NAMS: NewAmsterdam Pharma Company N.V. Ordinary Shares Company Profile & Statistics

NewAmsterdam Pharma Company N.V. Ordinary Shares Profile

About

NewAmsterdam Pharma Holding B.V. is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases. NewAmsterdam Pharma Holding B.V., formerly known as Frazier Lifesciences Acquisition Corporation, is based in MENLO PARK, Calif.

Info & Links

CEO

Michael Davidson

Headquarters

GOOIMEER 2-35
NARRDEN, P7 1411 DC, NETHERLANDS

Auditor

Deloitte Accountants B.V.

Share holders

Employees

100

NewAmsterdam Pharma Company N.V. Ordinary Shares Statistics

Valuation Measures

Market Capitalization²

3.56B

Enterprise Value

3.07B

Enterprise Value/EBITDA(ttm)

-13.62

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

153.33

Price to Book(mrq)

5.02

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-879.39%

Profit Margin(ttm)

-64060.32%

Return on Equity(ttm)

-26.67%

Return on Invested Capital(ttm)

-28.17%

Return on Assets(ttm)

-24.82%

Income Statement

Revenue(ttm)

22.50M

Revenue Per Share(ttm)

0.20

Gross Profit(ttm)

22.50M

EBITDA(ttm)³

-225.46M

Net Income Available to Common(ttm)

-203.82M

Diluted EPS(ttm)

-1.73

Share Statistics

Beta (5Y Monthly)

0.04

52-Week Change

29.03%

S&P 500 52-Week Change

15.40%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

114.98M

Dividend Yield

0.00%

Float⁴

91.01M

% Held by Insiders

20.84%

% Held by Institutions

89.89%

Balance Sheet

Total Cash(mrq)

637.56M

Total Cash Per Share(mrq)

5.55

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.88%

Quick Ratio(mrq)

7.88%

Book Value Per Share(mrq)

5.97

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.25

Free Cash Flow(ytd)

-148.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NAMS

NewAmsterdam Pharma Company N.V. Ordinary Shares